Earnings Feed
Start Free
Home/Filings/4/0001181431-13-040636
4//SEC Filing

Transcept Pharmaceuticals Inc 4

Accession 0001181431-13-040636

CIK 0001178711operating
View on SEC.govCompany Profile

Filed

Jul 17, 8:00 PM ET

Accepted

Jul 18, 6:11 PM ET

Size

5.3 KB

Accession

0001181431-13-040636

Insider Transaction Report

Form 4
Period: 2013-07-15
Transcept Pharmaceuticals IncTSPT
OCLASSEN GLENN A
DirectorPresident and CEO
Transactions
  • Award

    Common Stock Option (right to buy)

    2013-07-15+225,000→ 225,000 total
    Exercise: $2.93Exp: 2023-07-15→ Common Stock (225,000 underlying)
Footnotes (1)
  • [F1]The option vests in forty-eight equal monthly installments beginning on August 15, 2013.

Documents

1 file

Issuer

Transcept Pharmaceuticals Inc

CIK 0001178711

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001178711

Filing Metadata

Form type
4
Filed
Jul 17, 8:00 PM ET
Accepted
Jul 18, 6:11 PM ET
Size
5.3 KB
View on SEC.gov